This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Zacks Initiates Coverage of Healthcare Triangle With Underperform Recommendation
by Debanjana Dey
Discover why Zacks rates Healthcare Triangle as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore HCTI's heavy reliance on top clients amid liquidity issues and ongoing losses.
HCTINegative Net Change
medical medical-devices
Avanos Medical Stock May Gain From Brand Partnership With NFL
by Zacks Equity Research
AVNS' GAME READY announces a paid partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change AVNSNegative Net Change
medical medical-devices
SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio
by Zacks Equity Research
Stryker unveils two new products, enhancing precision and outcomes in foot and ankle surgeries.
BSXPositive Net Change DGXNegative Net Change SYKNegative Net Change DVAPositive Net Change
medical medical-devices
Factors Driving Veeva Stock More Than 20% in Three Months
by Zacks Equity Research
Robust quarterly results on the back of new partnerships and rising subscription revenues are driving VEEV's shares.
BSXPositive Net Change DGXNegative Net Change DVAPositive Net Change VEEVPositive Net Change
medical medical-devices
PacBio Stock Drops After Singapore Collaboration for HiFi Sequencing
by Zacks Equity Research
PACB's HiFi sequencing powers the HiFi Consortium's global effort to enhance the diagnosis and treatment of subfertility and recurrent pregnancy loss.
DGXNegative Net Change UHSPositive Net Change PACBNegative Net Change AVAHPositive Net Change
medical medical-devices
Lifeway Foods (LWAY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
LWAYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Modiv Industrial, Inc. (MDV) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
MDVNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, The Cooper Companies (COO)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
COONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Owens & Minor Stock to Gain From New Collaboration With Google Cloud
by Zacks Equity Research
OMI announces partnership with Google Cloud to enhance existing QSight capabilities.
BSXPositive Net Change OMINegative Net Change AXGNNegative Net Change GOOGLPositive Net Change
medical medical-devices
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy
by Zacks Equity Research
SOLV announces the launch of its V.A.C. Peel and Place Dressing for providing efficient and effective care in case of negative pressure wound therapy.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change SOLVNegative Net Change
medical medical-devices
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
by Zacks Equity Research
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change PACBNegative Net Change
medical medical-devices
PacBio's Stock Up on Munster Deal for Male Infertility Research
by Zacks Equity Research
PACB collaborates with the University Hospital of Munster, using Revio HiFi sequencing to advance research on male infertility and rare diseases in Germany and globally.
DGXNegative Net Change UHSPositive Net Change PACBNegative Net Change AVAHPositive Net Change
medical medical-devices
Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?
by Urmimala Biswas
MDT stock breaking above its 200 and 50-day SMAs can be a piece of good news for investors, signaling an uptrend.
ABTNegative Net Change BSXPositive Net Change BDXNegative Net Change MDTNegative Net Change
medical medical-devices
Should You Continue to Retain OMCL Stock in Your Portfolio Now?
by Zacks Equity Research
Omnicell is well-placed for growth in the upcoming quarters owing to its progress in achieving the Autonomous Pharmacy goal.
BSXPositive Net Change OMCLPositive Net Change AXGNNegative Net Change TMDXNegative Net Change
medical medical-devices
Glaukos Stocks Rides on Strong Product Demand Amid Competition
by Zacks Equity Research
GKOS continues to benefit from a robust product portfolio and a strong pipeline. However, stiff competition remains a woe.
BSXPositive Net Change DGXNegative Net Change DVAPositive Net Change GKOSNegative Net Change
medical medical-devices
LH Stock Expected to Gain From the Ballad Health Acquisition Deal
by Zacks Equity Research
Labcorp has reached an agreement to purchase select outreach laboratory services from Ballad Health.
BSXPositive Net Change LHNegative Net Change AXGNNegative Net Change SIBNNegative Net Change
medical medical-devices
MASI Stock Down Despite New SafetyNet Deal for Neonatal Care
by Zacks Equity Research
The latest adoption of Masimo's SafetyNet is likely to improve the care provided to premature newborns and facilitate their early discharge from the hospital.
BSXPositive Net Change DGXNegative Net Change DVAPositive Net Change MASIPositive Net Change
medical medical-devices
iRhythm Stock Gains Following Favorable Zio Monitor Study Data
by Zacks Equity Research
IRTC announces initial findings demonstrating the superior real-world performance of the next-generation Zio LTCM Monitor at the HRX 2024 meeting.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change IRTCNegative Net Change
medical medical-devices
Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device
by Zacks Equity Research
FEMY gains after FDA clearance for FemChec, a fallopian tube diagnostic tool designed for safe, in-office use, enhancing non-surgical birth control procedures.
DGXNegative Net Change UHSPositive Net Change AVAHPositive Net Change FEMYNegative Net Change
medical medical-devices
Here's Why You Should Retain PDCO Stock in Your Portfolio for Now
by Zacks Equity Research
Investors remain optimistic about Patterson Companies on the back of its broad product line.
BSXPositive Net Change DGXNegative Net Change DVAPositive Net Change PDCONegative Net Change
medical medical-devices
HSIC Stock Likely to Get a Boost From New Henry Schein One Launches
by Zacks Equity Research
Henry Schein's dental software arm unveils Dentrix Eligibility offerings to elevate the insurance verification process.
BSXPositive Net Change HSICNegative Net Change AXGNNegative Net Change SIBNNegative Net Change
medical medical-devices
Top Research Reports for JPMorgan, Thermo Fisher & Arista Networks
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Thermo Fisher Scientific Inc. (TMO) and Arista Networks, Inc. (ANET), as well as two micro-cap stocks United Homes Group, Inc. (UHG) and GSI Technology, Inc. (GSIT).
JPMPositive Net Change TMONegative Net Change KLACNegative Net Change ANETPositive Net Change TRGPPositive Net Change GSITNegative Net Change HWMPositive Net Change UHGPositive Net Change
communications computers finance medical-devices
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
by Zacks Equity Research
GKOS continues to benefit from a robust demand for its products as well as expansion in new markets. A strong development pipeline raises optimism.
BSXPositive Net Change DGXNegative Net Change DVAPositive Net Change GKOSNegative Net Change
medical medical-devices
Fresenius Medical Care Stock Rises on NxStage VersiHD Launch
by Zacks Equity Research
FMS introduces NxStage VersiHD with GuideMe Software to simplify home dialysis and grow its patient base in the United States.
DGXNegative Net Change UHSPositive Net Change FMSNegative Net Change ABMPositive Net Change
medical medical-devices
VEEV Stock Up Following the Release of New Features of Veeva Site Connect
by Zacks Equity Research
Veeva Systems' Site Connect is likely to aid the sponsors in reducing trial time and expense.
BSXPositive Net Change DGXNegative Net Change DVAPositive Net Change VEEVPositive Net Change
medical medical-devices